Concepedia

Wanda Williams

WW

Statistics

Publications

11

Citations

371

H-Index

11

Active since

1993

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

University of Maryland, Baltimore

University of Oklahoma Health Sciences Center

Wanda Williams is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in pharmacology, medicine, and ligand binding.

Publications per year

1993–2008

11

Publications

11

Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinity

Wayne D. Bowen, Bertold J. Vilner, Wanda Williams et al. · European Journal of Pharmacology · 1995 · 94 citations

, , +12

N-alkyl substituted analogs of the σ receptor ligand BD1008 and traditional σ receptor ligands affect cocaine-induced convulsions and lethality in mice

Rae R. Matsumoto, Kari A. McCracken, Buddy Pouw et al. · European Journal of Pharmacology · 2001 · 66 citations

, , +8

N-Arylalkylpiperidines as High-Affinity Sigma-1 and Sigma-2 Receptor Ligands: Phenylpropylamines as Potential Leads for Selective Sigma-2 Agents

Dean Y. Maeda, Wanda Williams, Wes E. Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 37 citations · Full text

, , +8

Novel analogs of the σ receptor ligand BD1008 attenuate cocaine-induced toxicity in mice

Rae R. Matsumoto, Deborah L. Gilmore, Buddy Pouw et al. · European Journal of Pharmacology · 2004 · 35 citations

, , +12

1,4-Dibenzylpiperazines possess anticocaine activity

Abby Foster, Huifang Wu, Weibin Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 28 citations · Full text

, , +4

1–5 of 11